Obesity
Conditions
Interventions
IH group:Individualized homeopathy treatment
IHP group: Individualized homeopathy placebo
IH+ACE group:Individualized homeopathy and acupoint catgut embedding
IHP+ sham ACE group:Individualized homeopathy placebo and sham acupoint catgut embedding
Sponsors
National Polytechnic Institute
Eligibility
Sex/Gender
All
Age
18 Years to 44 Years
Inclusion criteria
Inclusion criteria: Patients of both sexes aged 18 to 44 years. Diagnosis of overweight or obesity according to WHO criteria (BMI =25 kg/m²). Willingness to participate voluntarily in the study. Signed informed consent in accordance with NOM-004-SSA3-2012 for medical records
Exclusion criteria
Exclusion criteria: Present chronic or acute illnesses. Be pregnant or breastfeeding. Be under medical treatment or psychotropic medication. Follow a dietary regimen. Have used weight-loss medications, gastric bypass, or supplements within 4 weeks prior to inclusion. Have exposure to metals or metal implants. Have received homeopathic, acupuncture, or complementary/alternative therapies within 6 weeks prior to inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropometry: Waist circumference, hip circumference,body Mass Index. ,waist-hip ratio ;Impact of Weight on Quality of Life;Depression, Anxiety, and Stress Scale;Biochemical assessments: fasting glucose, total cholesterol, and total triglycerides ;Cytokine assessment: leptin, adiponectin, tumor necrosis factor alpha, Interleukin-6, and insulin;Metabolic indicators: homeostatic model assessment for insulin resistance, homeostatic model assessment for beta-cell function, quantitative insulin sensitivity check index, triglyceride-glucose index, triglyceride-glucose body mass index, leptin-to-adiponectin ratio, and homeostatic model assessment-adiponectin index .; | — |
Countries
Mexico
Contacts
Public ContactGilberto Garza-Treviño
Escuela Nacional de Medicina y Homeopatía
Outcome results
None listed